Intrinsic Value of S&P & Nasdaq Contact Us

Doximity, Inc. DOCS NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
88/100
6/7 Pass
SharesGrow Intrinsic Value
$46.95
+111%
Analyst Price Target
$45.87
+106.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Doximity, Inc. (DOCS) trades at a trailing P/E of 16.5, forward P/E of 14.4. Trailing earnings yield is 6.05%, forward earnings yield 6.95%. PEG 0.30 (Peter Lynch undervalued ≤1.0). Graham Number is $12.25.

Criteria proven by this page:

  • VALUE (83/100, Pass) — P/E is below market average (16.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.30); analyst target implies upside (+106.2%); earnings yield beats bond yields (6.05%).
  • Forward P/E 14.4 (down from trailing 16.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.30 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 6.05% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.95% as earnings recover.
  • Analyst consensus target $45.87 (+106.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 88/100 with 6/7 criteria passed.

SharesGrow 7-Criteria Score
88/100
SG Score
View full scorecard →
VALUE
83/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
66/100
→ Income
GROWTH
80/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — DOCS

Valuation Multiples
P/E (TTM)16.5
Forward P/E14.4
PEG Ratio0.30
Forward PEG0.37
P/B Ratio4.04
P/S Ratio6.21
EV/EBITDA14.3
Per Share Data
EPS (TTM)$1.28
Forward EPS (Est.)$1.55
Book Value / Share$5.22
Revenue / Share$3.40
FCF / Share$1.66
Yields & Fair Value
Earnings Yield6.05%
Forward Earnings Yield6.95%
Dividend Yield0.00%
Graham Number$12.25
SharesGrow IV$46.95 (+111%)
Analyst Target$45.87 (+106.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 1,229.4 0.00 198.57 112.38 -
2020 323.8 0.19 8,477.32 82.74 -
2021 188.1 1.86 141.51 45.65 -
2022 55.0 0.10 9.69 24.79 -
2023 55.4 -1.95 6.47 14.93 -
2024 34.0 0.99 5.57 10.56 -
2025 48.6 0.92 10.01 19.01 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.05 $85.7M $7.83M 9.1%
2020 $0.06 $116.39M $29.74M 25.5%
2021 $0.12 $206.9M $50.21M 24.3%
2022 $0.70 $343.55M $154.78M 45.1%
2023 $0.53 $419.05M $112.82M 26.9%
2024 $0.72 $475.42M $147.58M 31%
2025 $1.11 $570.4M $223.19M 39.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.55 $1.49 – $1.60 $643.34M $643.06M – $643.52M 14
2027 $1.62 $1.41 – $1.93 $701.15M $680.26M – $716.09M 13
2028 $1.80 $1.49 – $2.27 $768.23M $768.22M – $768.24M 8
2029 $1.95 $1.93 – $1.97 $824.4M $824.4M – $824.4M 2
2030 $2.41 $2.29 – $2.57 $989.2M $952.52M – $1.04B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message